Results 211 to 220 of about 107,930 (357)

Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT Relapsed/refractory multiple myeloma (RRMM) patients with dialysis‐dependent renal impairment face limited therapeutic options due to exclusion from clinical trials, a lack of evidence‐based guidelines, and inferior outcomes. Bispecific antibodies targeting B‐cell maturation antigen (BCMA) have shown promise in RRMM treatment but remain ...
Michèle Hoffmann, Barbara Jeker, Uyen Huynh‐Do, Yara Banz, Jeanne Godau, Elisabeth Weber, Ulrike Bacher, Thomas Pabst   +7 more
wiley   +1 more source

Educational lecture on clinical features and DNA diagnosis of familial amyloidotic polyneuropathy.

, 1987
Shukuro Araki
openalex   +2 more sources

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy

Brain : a journal of neurology, 2017
E. Delmont, Constance Manso, L. Querol, A. Cortese, A. Berardinelli, A. Lozza, M. Belghazi, P. Malissart, P. Labauge, G. Taieb, N. Yuki, I. Illa, S. Attarian, J. Devaux   +13 more
semanticscholar   +1 more source

Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real‐World Data Approach

Journal of Inherited Metabolic Disease, Volume 48, Issue 4, July 2025.
ABSTRACT Neurodegeneration in metachromatic leukodystrophy (MLD) may be preceded by systemic complications. Characterization of these features is critical to define barriers to early diagnosis and treatment eligibility for gene therapy. We utilized medical billing (claims) datasets and a natural history study to capture pre‐diagnosis MLD‐related events.
Ali Mohajer, Anjana Sevagamoorthy, Karen Bean, Sylvia Mutua, Francis Pang, Laura Ann Adang   +5 more
wiley   +1 more source

Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy [PDF]

, 1999
Masaaki Nagamatsu, S Terao, K. Misu, May X Li, Nobutaka Hattori, M. Ichimura, Masaki Sakai, Hiroko Yamamoto, Hirohisa Watanabe, S Riku, Etsuro Ikeda, Jotaro Hata, Masaya Oda, Motoharu Satake, Nobuhiro Nakamura, S Matsuya, Yoshio Hashizume, Gen Sobue   +17 more
openalex   +1 more source

Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis Defects

Journal of Inherited Metabolic Disease, Volume 48, Issue 4, July 2025.
ABSTRACT Bile acid synthesis defects (BASDs) comprise a group of rare, often severe, metabolic disorders. Bile acid replacement therapy decreases toxic bile acid intermediates production and improves biochemical profiles, potentially delaying or stabilizing disease progression.
Yasmin Polak, Elles Marleen Kemper, Marc Engelen, Femke C. C. Klouwer, Kevin Berendse, Frédéric M. Vaz, Bart G. P. Koot, Eleonora (Noortje) L. Swart, Carla E. M. Hollak   +8 more
wiley   +1 more source

Validity and Responsiveness of Balance Measurements Using Posturography in Patients With Immune-Mediated Neuropathies. [PDF]

J Peripher Nerv Syst
Michael MR, van Veen R, Wieske L, Merkies ISJ, van Schaik IN, Eftimov F.   +5 more
europepmc   +1 more source

Hepatitis-C-associated multiple arterial dissection of cerebral vessels [PDF]

, 2003
Einsiedel, H. von, Hamann, Gerhard F., Sander, D., Zachoval, R.   +3 more
core   +1 more source

Interaction Between Microbiota and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and New Therapeutic Opportunities

MedComm, Volume 6, Issue 7, July 2025.
This review systematically concludes the interaction between microbiota and immunity. We introduce six phyla: Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucomicrobia. We also elucidate molecular mechanisms, biological functions, diseases, and new therapeutic opportunities between microbiota and immunity. .
Jingjing Zeng, Zimeng He, Guoqing Wang, Yuxin Ma, Feng Zhang   +4 more
wiley   +1 more source

Electrophysiological-based automatic subgroups diagnosis of patients with chronic dysimmune polyneuropathies. [PDF]

J Neuroeng Rehabil
Ballanti S, Liuzzi P, Mattiolo PL, Scarpino M, Matà S, Hakiki B, Cecchi F, Oddo CM, Mannini A, Grippo A.   +9 more
europepmc   +1 more source